Cart
sales@molnova.com
Denzimol
CAS No. 73931-96-1
Denzimol( —— )
Catalog No. M36156 CAS No. 73931-96-1
Denzimol is a novel anticonvulsant compound.Denzimol is selective for tonic seizures.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 137 | Get Quote |
|
| 5MG | 200 | Get Quote |
|
| 10MG | 295 | Get Quote |
|
| 25MG | 539 | Get Quote |
|
| 50MG | 727 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1971 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDenzimol
-
NoteResearch use only, not for human use.
-
Brief DescriptionDenzimol is a novel anticonvulsant compound.Denzimol is selective for tonic seizures.
-
DescriptionDenzimol is a novel anticonvulsant compound.Denzimol is selective for tonic seizures.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number73931-96-1
-
Formula Weight292.37
-
Molecular FormulaC19H20N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CN1C=CN=C1)(O)C2=CC=C(CCC3=CC=CC=C3)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CD38 inhibitor 1
CD38 inhibitor 1 is an inhibitor of CD38. For hCD38 and mouse CD38, the IC50s are 7.3 nM and 1.9 nM.
-
JI-101
JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
-
CDK2
CDK2 is a member of the eukaryotic S/T protein kinase family and its function is to catalyze the phosphoryl transfer of ATP γ-phosphate to serine or threonine hydroxyl (denoted as S0/T0) in a protein substrate.
